JP2003505350A5 - - Google Patents

Download PDF

Info

Publication number
JP2003505350A5
JP2003505350A5 JP2001511185A JP2001511185A JP2003505350A5 JP 2003505350 A5 JP2003505350 A5 JP 2003505350A5 JP 2001511185 A JP2001511185 A JP 2001511185A JP 2001511185 A JP2001511185 A JP 2001511185A JP 2003505350 A5 JP2003505350 A5 JP 2003505350A5
Authority
JP
Japan
Prior art keywords
acid sequence
amino acid
pro
polypeptide
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001511185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003505350A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/006884 external-priority patent/WO2001005972A1/en
Publication of JP2003505350A publication Critical patent/JP2003505350A/ja
Publication of JP2003505350A5 publication Critical patent/JP2003505350A5/ja
Pending legal-status Critical Current

Links

JP2001511185A 1999-07-20 2000-03-15 免疫関連疾患の治療のための組成物と方法 Pending JP2003505350A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14475899P 1999-07-20 1999-07-20
US60/144,758 1999-07-20
PCT/US2000/006884 WO2001005972A1 (en) 1999-07-20 2000-03-15 Compositions and methods for the treatment of immune related diseases

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2002270824A Division JP2003189880A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法
JP2002270825A Division JP2003180381A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2003505350A JP2003505350A (ja) 2003-02-12
JP2003505350A5 true JP2003505350A5 (https=) 2007-05-10

Family

ID=22510005

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001511185A Pending JP2003505350A (ja) 1999-07-20 2000-03-15 免疫関連疾患の治療のための組成物と方法
JP2002270824A Pending JP2003189880A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法
JP2002270825A Pending JP2003180381A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2002270824A Pending JP2003189880A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法
JP2002270825A Pending JP2003180381A (ja) 1999-07-20 2002-09-17 免疫関連疾患の治療のための組成物と方法

Country Status (8)

Country Link
EP (1) EP1198568B1 (https=)
JP (3) JP2003505350A (https=)
AT (1) ATE368110T1 (https=)
AU (1) AU4011300A (https=)
CA (1) CA2375458A1 (https=)
DE (1) DE60035693T2 (https=)
ES (1) ES2291198T3 (https=)
WO (1) WO2001005972A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689607B2 (en) 1997-10-21 2004-02-10 Human Genome Sciences, Inc. Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US6503184B1 (en) 1997-10-21 2003-01-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US7589172B2 (en) 1999-07-20 2009-09-15 Genentech, Inc. PRO256 polypeptides
IL149849A0 (en) * 1999-12-09 2002-11-10 Sankyo Co A method and kit for testing an agent for treatment of hyperlipemia
DK1255829T3 (da) 2000-02-11 2009-12-14 Genentech Inc Inhibitor af hepatocytvækstfaktoraktivator til anvendelse i modulation af angiogenese og kardiovaskularisering
WO2003009865A1 (en) * 2001-07-25 2003-02-06 Genset S.A. Agonists and antagonists of energen for use in the treatment of metabolic disorders
WO2003049758A1 (en) * 2001-12-13 2003-06-19 Genset S.A. Emergen agonists and antagonists for use in the treatment of metabolic disorders
JP5401001B2 (ja) 2002-09-11 2014-01-29 ジェネンテック， インコーポレイテッド 免疫関連疾患の治療のための新規組成物と方法
AU2005244742A1 (en) * 2004-05-12 2005-12-01 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
SG10202112838YA (en) 2008-04-09 2021-12-30 Genentech Inc Novel compositions and methods for the treatment of immune related diseases
JP5602850B2 (ja) 2009-07-14 2014-10-08 ザ スクリプス リサーチ インスティテュート 間葉幹細胞分化
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
MA38369B1 (fr) 2013-03-08 2018-10-31 Novartis Ag Peptides et compositions pour le traitement d'une lesion de l'articulation
BR112016000853A2 (pt) 2013-07-16 2017-12-12 Genentech Inc métodos para tratar ou retardar, reduzir ou inibir a recidiva ou a progressão do câncer e a progressão de uma doença imune-relacionada em um indivíduo, para aumentar, melhorar ou estimular uma resposta ou função imune em um indivíduo e kit
PE20181046A1 (es) 2015-09-25 2018-07-03 Genentech Inc Anticuerpos anti-tigit y metodos de uso
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
DE69631500T2 (de) * 1995-07-24 2004-12-02 Mitsubishi Chemical Corp. Inhibitor des Hepatozytwachstumsfaktoraktivators
US5874230A (en) * 1996-07-10 1999-02-23 Tularik, Inc. Assays using TRAF2-associated protein kinase polypeptides
WO1998011138A1 (en) * 1996-09-12 1998-03-19 Human Genome Sciences, Inc. Chemokine alpha-4
WO1998024908A1 (en) * 1996-12-05 1998-06-11 Human Genome Sciences, Inc. Human chemokine beta-13
WO1998025959A2 (en) * 1996-12-11 1998-06-18 Chiron Corporation Secreted human proteins
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
AU3661199A (en) * 1998-04-27 1999-11-16 Zymogenetics Inc. Novel polypeptide growth factors and materials and methods for making them
US6171790B1 (en) * 1998-05-01 2001-01-09 Incyte Pharmaceuticals, Inc. Human protease associated proteins
EP1078046A4 (en) * 1998-05-12 2005-05-11 Human Genome Sciences Inc 97 HUMAN SECRETED PROTEINS
SV1999000069A (es) * 1998-06-02 2000-04-11 Lilly Co Eli Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
AU4643699A (en) * 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences
JP2007222001A (ja) * 1998-11-17 2007-09-06 Sagami Chem Res Center 疎水性ドメインを有するヒトタンパク質及びそれをコードするｄｎａ
AU1181900A (en) * 1998-11-17 2000-06-05 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins
JP3695642B2 (ja) * 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
ES2327785T3 (es) * 1998-12-22 2009-11-03 Genentech, Inc. Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasticas.
JP2000325087A (ja) * 1999-05-21 2000-11-28 Otsuka Pharmaceut Co Ltd Ｔｓａ２３０６遺伝子

Similar Documents

Publication Publication Date Title
JP4145314B2 (ja) 腫瘍細胞成長阻害のための組成物及び方法
US7294696B2 (en) PRO7168 polypeptides
JP4451059B2 (ja) 分泌及び膜貫通ポリペプチドとそれをコードする核酸
JP2004516227A (ja) 免疫関連疾患を治療するための組成物と方法
JP2003505082A (ja) 新規なポリヌクレオチドとその使用法
JP2012254093A (ja) 免疫関連疾患の治療のための新規組成物と方法
US7282570B2 (en) Compositions and methods for the treatment of immune related diseases
JP2006515167A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2003505350A5 (https=)
JP2008301810A (ja) 免疫関連疾患を治療するための組成物及び方法
EP1198568B1 (en) Compositions and methods for the treatment of immune related diseases
US7282562B2 (en) Compositions and methods for the treatment of immune related diseases
JP2005519590A (ja) 免疫関連疾患の治療のための組成物及び方法
JP2003530082A6 (ja) 免疫関連疾患を治療するための組成物及び方法
US7304136B2 (en) PRO4407 polypeptides
US7601514B2 (en) Nucleic acid encoding PRO10268 polypeptides
JP3988821B2 (ja) 免疫関連疾患を治療するための組成物及び方法
US7235642B1 (en) Anti-PRO 1313 antibodies
US20060073556A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7365157B2 (en) PRO9912 polypeptides
US7344880B2 (en) Nucleic acid encoding PRO9912 polypeptides
EP1529842A2 (en) Compositions and methods for the treatment of immune related diseases
EP1878795A2 (en) Compositions and methods for the treatment of immune related diseases
JP2003524406A (ja) 腫瘍細胞成長阻害のための組成物及び方法